Andrea K. Mccollum

Array ( [id] => 8278416 [patent_doc_number] => 20120172286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'THERAPEUTIC USE FOR ALPHA1 PROTEINASE INHIBITOR IN HEMATOPOIESIS' [patent_app_type] => utility [patent_app_number] => 13/302821 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19581 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13302821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134338 [patent_doc_number] => 20130295052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'NOVEL CONJUGATES FOR TARGETED DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/988428 [patent_app_country] => US [patent_app_date] => 2011-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9757 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122057 [patent_doc_number] => 20130288979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Inhibitors of Apoptosis and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/885956 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12800 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140278 [patent_doc_number] => 08580739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Methods of reducing myocardial injury following myocardial infarction' [patent_app_type] => utility [patent_app_number] => 13/299096 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13299096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10925770 [patent_doc_number] => 20140328791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Conjugates of an IL-2 Moiety and a Polymer' [patent_app_type] => utility [patent_app_number] => 13/884901 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23427 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13093383 [patent_doc_number] => 10066024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Methods of generating antibodies to metalloenzymes [patent_app_type] => utility [patent_app_number] => 13/882192 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 12817 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10162544 [patent_doc_number] => 09193761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Method for purifying human granulocyte-colony stimulating factor from recombinant E. coli' [patent_app_type] => utility [patent_app_number] => 13/881637 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6660 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905229 [patent_doc_number] => 20140308242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'BIOMARKERS FOR HCV INFECTED PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/879736 [patent_app_country] => US [patent_app_date] => 2011-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23834 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977248 [patent_doc_number] => 20130210678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'MOESIN FRAGMENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/878230 [patent_app_country] => US [patent_app_date] => 2011-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14309 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10627624 [patent_doc_number] => 09345764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Moesin modulators and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/878232 [patent_app_country] => US [patent_app_date] => 2011-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 14660 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057323 [patent_doc_number] => 09096669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Humanized anti-TNF-α antibody and antigen-binding fragment (Fab) thereof and use of the same' [patent_app_type] => utility [patent_app_number] => 13/876774 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11024 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10837498 [patent_doc_number] => 08865170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier' [patent_app_type] => utility [patent_app_number] => 13/876265 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18984 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778245 [patent_doc_number] => 20120040893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'MODIFICATION OF FEEDING BEHAVIOUR' [patent_app_type] => utility [patent_app_number] => 13/241520 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 42370 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040893.pdf [firstpage_image] =>[orig_patent_app_number] => 13241520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9033835 [patent_doc_number] => 20130236473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'THERAPEUTIC AGENTS AND PROPHYLACTIC AGENTS FOR SYMPTOMS ACCOMPANYING AUTOIMMUNE DISEASES, INFLAMMATORY DISEASES, ALLERGY DISEASES AND ORGAN TRANSPLANTS' [patent_app_type] => utility [patent_app_number] => 13/823325 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14448 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382323 [patent_doc_number] => 20120225954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE CLASSIFICATION OF NON-SMALL CELL LUNG CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/223862 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22228 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13223862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892453 [patent_doc_number] => 20130165637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'USE OF G-CSF DIMER IN THE TREATMENT OF NEUTROPENIA' [patent_app_type] => utility [patent_app_number] => 13/819716 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8013 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8841144 [patent_doc_number] => 20130136772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'REGULATION OF IMMUNE RESPONSE BY COLOCYNTHIN AND/OR ITS DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/814027 [patent_app_country] => US [patent_app_date] => 2011-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7068 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891121 [patent_doc_number] => 20130164305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'METHOD FOR TARGET AND DRUG VALIDATION IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 13/819416 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14633 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884755 [patent_doc_number] => 20130157939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'COMPOSITIONS FOR GASTRIC DELIVERY OF ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/817931 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7942 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976059 [patent_doc_number] => 20130209489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Antibodies That Bind Myostatin, Compositions And Methods' [patent_app_type] => utility [patent_app_number] => 13/816894 [patent_app_country] => US [patent_app_date] => 2011-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20750 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816894 [rel_patent_id] =>[rel_patent_doc_number] =>)